
Steven Schachter
RADx Chief; Professor
Harvard Medical School

Lisa Suennen
Lead, Digital & Technology Group
Manatt Ventures

Sir Mark Caulfield
CEO
Barts Life Sciences

Jessica L. Mega
Co-Founder & CSO
Verily

Robert C. Green
Director, G2P Program
Brigham and Women's Hospital

Jeffrey Venstrom
Chief Medical Partner
Cross Portfolio, Genentech

Timothy Stenzel
Director, In Vitro Diagnostics
And Radiological Health
FDA

Ruth March
SVP & Head, Precision Medicine
AstraZeneca

Howard I. Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Mara Aspinall
Managing Director
BlueStone Venture Partners

Tom Miller
Founder, Managing Partner
GreyBird Ventures

Lara Jehi
Chief Research Information Officer
Cleveland Clinic

Vincent Mikol
Head, Translational Sciences,
Sanofi

Megan Mahoney
Chief of Staff
Stanford Health Care

Michael Snyder
Director, Genomics & Personalized Medicine
Stanford Univ

Esther Babady
Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Jürgen Scheuenpflug
Global Head, Biomarkers and Companion Diagnostics
Merck

Edward Abrahams
President
Personalized Medicine Coalition

Dan Theodorescu
Director
Cedars-Sinai Cancer Center

Razelle Kurzrock
Chair
Worldwide Innovative Network (WIN) for Personalized Cancer Therapy

Nathan D. Price
CSO
Thorne HealthTech

Shirin Khambata Ford
Global Head, Companion Diagnostics
Daiichi Sankyo

Adam Dakin
Partner, Healthtech
Dreamit Ventures

Pia Davidsson
Head, Experimental Medicine
AstraZeneca

John Quackenbush
Chair, Biostatistics
Harvard